OUR TEAM

Kaitlin Farrell

Partner

Kaitlin Farrell

Partner

Ms. Farrell relies on her technical background, trial experience, and competitive drive to develop results-oriented strategies and achieve favorable outcomes for clients.
Ms. Farrell relies on her technical background, trial experience, and competitive drive to develop results-oriented strategies and achieve favorable outcomes for clients.

OVERVIEW

Kaitlin Farrell has extensive patent law experience, focused primarily on patent litigation and pre-lawsuit investigations in matters related to pharmaceuticals, medical devices, chemicals, cosmetics, food/beverage, automotives, and consumer products. Kaitlin has developed significant trial and appellate experience that informs all elements of her litigation and due diligence practice. Kaitlin has worked with ADHD, hemophilia A, major depressive disorder, acne vulgaris, vulvar and vaginal atrophy, and hereditary angioedema drugs; extended-release, extended half-life, topical, and subcutaneous pharmaceutical formulations; and crystalline and recombinant drug products.

Kaitlin has litigated major patent disputes before the PTAB, the ITC, and in major patent venues across the country. She has also represented clients before U.S. Court of Appeals for the Federal Circuit. She is an active contributor to local, national, and international intellectual property associations.

REPRESENTATIVE CASES

  • Galderma Labs., LP v. Taro Pharmaceuticals Inc., No. 24-cv-00333 (D.N.J) & Galderma Labs., LP v. Teva Pharmaceuticals Inc., No. 24-cv-00197 (D.N.J)
  • Voesh Corp. v. Codi N Codi Inc., No. 23-cv-02672 (S.D.N.Y. 2023)
  • Takeda Pharmaceutical Co. Ltd. et al. v. Norwich Pharmaceuticals Inc., No. 20-8966 (D.N.J. Dec. 27, 2022), aff’d, No. 2023-1374 (Fed. Cir. May 4, 2023)
  • Jens H.S. Nygaard v. FĂ©dĂ©ration Internationale De L’automobile et al., No. 20-00234 (W.D. Tex.)
  • Barnett v. Surefire Medical, Inc., No. 17-02470 (D. Colo.)
  • 3D Scan Guide LLC v. Straumann USA LLC, No. 21-00459 (W.D. Tex.)
  • NOF Corp. v. Nektar Therapeutics. IPR2019-01397, Paper 70 (PTAB Aug. 5, 2021)
  • NOF Corp. v. Nektar Therapeutics, IPR2019-01392, -01395, -01396 (PTAB 2020)
  • CSL Behring v Shire Viropharma Inc., IPR2019-00459, Paper 8 (PTAB July 2, 2019)
  • Shire Orphan Therapies LLC et al v. Fresenius Kabi USA, LLC, No. 15-cv-01102 (D. Del.)
VIEW ALL

EDUCATION

  • Fordham University (B.S., Biological Sciences and Anthropology, 2013)
  • Notre Dame Law School (J.D., 2017)

BAR ADMISSIONS

  • The State Bar of New York
  • The State Bar of Florida
  • United States Court of Appeals for the Federal Circuit
  • Eastern District of New York
  • U.S. Patent and Trademark Office (Reg. No. 76,057)
VIEW ALL

MEMBERSHIPS

  • New York Intellectual Property Law Association
  • Federal Circuit Bar Association
  • Women in IP Network (WIN)
  • National Association of Women Lawyers (NAWL)
VIEW ALL

AWARDS

  • Super Lawyers® New York Metro Rising Stars (2023, 2024)
  • Named in “The Top Intellectual Property Attorneys for 2024” by Attorney Intel (Jan. 2025)
  • American Bar Association and Bloomberg BNA Award for Excellence in the Study of Intellectual Property Law
  • J. Franklin Ewing, SJ, Memorial Award (Fordham University Anthropology Department Honor)
VIEW ALL
Haug Partners

CONTACT

LOCATION

New York City
745 Fifth Avenue, 10th Floor,
New York, NY 10151
745 Fifth Avenue, 10th Floor, New York, NY 10151